IAN PELLETIER: Open Payments
NPI 1316501000 · PILOT KNOB, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 23 payments from 12 companies in 2025. Trend: 2023 $459 · 2024 $392 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $124 |
| Verona Pharma, Inc. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| ABBVIE INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $25 |
| Indivior Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Braeburn Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Ozempic, Ohtuvayre, CAPLYTA, Rybelsus, REXULTI, Prolastin-C Liquid, SUBLOCADE, OTEZLA.
Industry payments across MO — which companies pay providers there.
